The role of prasugrel in the management of acute coronary syndromes: a systematic review.
CONCLUSIONS: Prasugrel and ticagrelor are today the recommended first-line agents in patients with ACS. The estimation of which drug is superior over the other cannot be reliably established from the current trials.
PMID: 29131238 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Aspirin | Bleeding | Cardiology | Cardiovascular | Clopidogrel | Databases & Libraries | Drugs & Pharmacology | Heart | Heart Attack | PET Scan | Plavix | Stroke | Thrombosis